Journal
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS
Volume 8, Issue 4, Pages 252-254Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.dsx.2014.09.021
Keywords
Type 1 diabetes; T cell receptor; Complementarity determining region 3; Short review
Categories
Funding
- Provincial Science and Technology Development Project [2012YD18054]
- Provincial Nature Science Foundation [ZR2012HL29]
- project of Shandong Province Higer Educational Science and Technology Program [J11LF18]
- Population and Family Planning Commission [[2011] 13]
- Development Plan Project of Jining Science and Technology Bureau of Shandong Province [[2011] 57]
- Youth Foundation of Jining Medical College
- Miaopu Program of Affiliated Hospital of Jining Medical College [JYFYMP-2013-09]
Ask authors/readers for more resources
Although type 1 diabetes (T1D) is a common autoimmune disease, and there have been many experimental and clinical researches on it, yet the exact mechanisms still remain unclear. What is the fact without doubt that T cells play an important role in the progress of T1D. Because the identification of T cells depends on the identification of MHC which binds the peptides of auto-antigens, the responses of T cells specific to this combination might make the T cell receptor (TCR) genes changed, especially the complementarity determining region 3 (CDR3) genes. According to this theory, it is possible to unclose the immune mechanisms of T1D from the changes of the specific TCR. This paper focuses on the current studies of TCR relative to T1D. (C) 2014 Diabetes India. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available